Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Hyperlipidaemia
ADR ID BADD_A06050
ADR Hierarchy
14      Metabolism and nutrition disorders
14.08      Lipid metabolism disorders
14.08.03      Hyperlipidaemias NEC
14.08.03.001      Hyperlipidaemia
Description Conditions with excess LIPIDS in the blood. | Abnormally high level of lipids in blood. [MeSH]
MedDRA Code 10062060
MeSH ID D006949; D006951
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE)
Synonym
Hyperlipaemia | Hyperlipemia | Hyperlipidaemia NOS | Hyperlipidaemia secondary | Hyperlipidaemia, other and unspecified | Hyperlipidemia | Hyperlipoproteinemia | Other and unspecified hyperlipidaemia | Other and unspecified hyperlipidemia | Hyperlipidemia secondary | Hyperlipoproteinaemia | Hyperlipidaemia | Lipemia | Lipaemia | Hyperlipidemias | Hyperlipemias | Lipidemia | Lipidemias | Lipemias
ADR Related Proteins
Protein Name UniProt AC TTD Target ID
Cellular retinoic acid-binding protein 1P29762Not Available
Cytochrome P450 3A43Q9HB55Not Available
Retinoic acid receptor RXR-alphaP19793T13726
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00036Acitretin--
BADD_D00041Adalimumab--
BADD_D00066Alendronic acid--
BADD_D00076Allopurinol--
BADD_D00121Amlodipine--
BADD_D00132Amphotericin b--
BADD_D00151Apixaban--
BADD_D00159Arformoterol--
BADD_D00160Arformoterol tartrate--
BADD_D00165Aripiprazole--
BADD_D00175Asparaginase--
BADD_D00193Axitinib--
BADD_D00214Basiliximab--
BADD_D00233Benicar hydrochlorothiazide--
BADD_D00263Betaxolol--
BADD_D00269Bexarotene--
BADD_D00424Cevimeline--
BADD_D00425Cevimeline hydrochloride--
BADD_D00463Cidofovir--
BADD_D00464Cidofovir dihydrate--
BADD_D00466Cilostazol--
BADD_D00475Citalopram--
BADD_D00511Clozapine--
BADD_D00551Cyclosporine--
BADD_D00578Dapagliflozin--
BADD_D00586Darunavir--
BADD_D00589Dasatinib--
BADD_D00623Dexamethasone--
BADD_D00628Dexlansoprazole--
BADD_D00706Donepezil--
The 1th Page    1 2 3 4 5    Next   Last    Total 6 Pages